Gastrointestinal Health
Metabolic Connection
Mapping metabolic patterns across
six clinical categories that may help
contextualize complex gastrointestinal
presentations.
Gastrointestinal symptoms often reflect overlapping contributors: microbial imbalance, impaired mucosal barrier integrity, disrupted gut–brain signaling, and altered energy or nutrient demand. Patients are frequently left with unclear findings despite a standard structural workup.[2-4]
The Organic Acids Test (OAT) evaluates six interconnected metabolic categories at once: microbial, mitochondrial, neurotransmitter, methylation, nutrient, and toxicant pathways. Its pattern-based interpretation may help contextualize physiologic contributors to persistent, multisystem GI presentations.[1–8].
When Might Providers Consider Organic Acids Test (OAT)?
Neurologic & Mental Health – Metabolic Connection1
Suspected Fungal/Yeast Overgrowth:GI complaints alongside signs suggestive of Candida or related fungal overgrowth, which OAT’s yeast/fungal metabolite markers (arabinose and tartaric acid) may help contextualize.[2]
GI Symptoms with Overlapping Systemic Features: GI complaints co-occurring with fatigue, cognitive changes, or mood symptoms—suggesting gut–brain axis involvement, chronic fatigue, or mitochondrial contributors.[3,4,6]
Suspected Malabsorption or Nutrient Insufficiency: Signs of impaired protein digestion, nutrient depletion, or increased cofactor demand suggesting reduced digestive or absorptive capacity.[7]
| Analyte Class | What It Reflects | GI Relevance |
|---|---|---|
| Microbial Overgrowth | Markers of yeast, mold, bacteria, and Clostridium species, including named analytes such as HPHPA (Clostridia marker), 4-Cresol (C. difficile marker), DHPPA (beneficial bacteria marker), and yeast/fungal-associated markers such as arabinose and tartaric acid. | May help identify bacterial or fungal dysbiosis patterns relevant to bloating, gas, and altered bowel habits[2,8]. |
| Mitochondrial Health / Energy Markers | Krebs cycle and related intermediates of glucose, fatty acid, and amino acid metabolism reflecting cellular energy production. | May reflect metabolic reserve relevant to intestinal epithelial barrier maintenance and the energy-dependent repair processes needed for a healthy gut lining[5,6]. |
| Neurotransmitter Metabolites | Dopamine, serotonin, and norepinephrine/epinephrine pathway metabolites (e.g., 5-HIAA, HVA, VMA, quinolinic acid, kynurenic acid), reflecting turnover rather than synaptic levels. | Since a substantial proportion of the body’s serotonin pathway activity originates in the gut, these markers may offer indirect insight into gut–brain signaling relevant to motility, visceral sensitivity, and symptom overlap[3,4]. |
| Methylation / Detoxification | Metabolites reflecting methyl group cycling, glutathione status (e.g., N-acetylcysteine, a glutathione precursor), and nutrients involved in both methylation and detoxification. | May provide context when impaired detoxification capacity or glutathione depletion is contributing to gut barrier or mitochondrial stress alongside GI symptoms[5]. |
| Toxic Exposure | Metabolites influenced by heavy metals, environmental toxins, or mold/mycotoxin exposure, along with associated oxidative stress and glutathione depletion. | May provide context when environmental toxicant or mycotoxin burden is contributing to gut barrier or mitochondrial stress alongside GI symptom presentations[5]. |
| Nutrient Needs | Direct and indirect biomarkers reflecting functional demand for B-vitamins (B2, B5, B6, B12, biotin), CoQ10, and other key micronutrients. | May indicate increased biochemical demand associated with malabsorption or reduced digestive/absorptive capacity, relevant to patients with suspected nutrient insufficiency[7]. |
Cross-Domain Pattern Recognition
OAT evaluates six interconnected metabolic categories simultaneously, enabling pattern-based interpretation across microbial, mitochondrial, neurotransmitter, methylation, nutrient, and toxicant pathways that may be relevant to multisystem gastrointestinal presentations[2,5,6].
Physiologic Context for Complex Presentations
In patients with overlapping GI, systemic, and gut–brain symptoms, OAT findings may help identify metabolic contributors not captured by standard workup, supporting more informed clinical reasoning[1,3].
Cofactor & Nutrient Demand Assessment
Nutrient-related and mitochondrial markers may indicate increased biochemical demand for vitamin-dependent cofactors supporting digestive enzyme function and epithelial repair—providing actionable context for individualized support strategies[5,7].
Response monitoring:
Repeating a pattern-based metabolite assessment can support longitudinal clinical reasoning when dietary, antimicrobial, nutrient, or environmental interventions are being evaluated. [7,9,16]
How to Order
Neurologic & Mental Health – Metabolic Connection1
To order the Organic Acids Test (OAT), register for a portal account. Specimen collection kits and requisition forms are available through your account portal. For clinical support or interpretation questions, contact our clinical education team.
Explore Other Gastrointestinal Health Lenses:
This webpage is intended for licensed healthcare professionals and is for informational and educational purposes only. The test results are not intended to diagnose, treat, cure, or prevent disease. All clinical interpretation should be done by a qualified healthcare professional in the context of the individual patient. Statements regarding associations between health symptoms and conditions do not constitute diagnostic claims.
References
- Sivsammye G, Sims HV. Presumptive identification of Clostridium difficile by detection of p-cresol (4-cresol) in prepared peptone yeast glucose broth supplemented with p-hydroxyphenylacetic acid. J Clin Microbiol. 1990;28(8):1851–1853. doi:10.1128/jcm.28.8.1851-1853.1990.
- Lord RS, Bralley JA. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Altern Med Rev. 2008;13(4):292–306.
- Shaikh SD, Sun N, Canakis A, Park WY, Weber HC. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. J Clin Med. 2023;12(7):2558. doi:10.3390/jcm12072558.
- Napolitano M, Fasulo E, Ungaro F, et al. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms. 2023;11(10):2369. doi:10.3390/microorganisms11102369.
- Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. doi:10.1155/2015/628157.
- Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62. doi:10.3389/fcell.2015.00062.
- Celiac Disease. Merck Manual Professional Edition, Gastroenterology section. Accessed July 2026.
- Shaw W. Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci. 2010;13(3):135-143. doi:10.1179/147683010X12611460763968
All trademarks are owned by the company and its affiliates. ©2026 Mosaic Diagnostics. All Rights Reserved. MDX_GI_OAT_10-2026.v1